Abstract
Beta-blockers have long been used to treat hypertension and are recommended as first-line therapy in hypertension guidelines. However, their benefits have been challenged by other antihypertensive treatments. A recent meta-analysis of atenolol trials has also cast doubt on the value of this beta-blocker in primary hypertension (Journal Watch Cardiology Feb 4 2005). For a new meta-analysis, researchers …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
